Literature DB >> 3722202

Comparative studies of two cathepsin B isozymes from porcine spleen. Isolation, polypeptide chain arrangements, and enzyme specificity.

T Takahashi, S Yonezawa, A H Dehdarani, J Tang.   

Abstract

Our previous studies on carbohydrate structures of purified porcine spleen cathepsin B indicated that there are two cathepsin B isozymes, each containing a different carbohydrate (Takahashi, T., Schmidt, P.G., and Tang, J. (1984) J. Biol. Chem. 259, 6059-6062). We have now isolated these two enzymes and carried out a comparative study on their structures and enzymic properties. The major isozyme (CB-I) is a two-chain enzyme (Mr = 28,000) with a light chain (Mr = 5,000) and a heavy chain (Mr = 23,000), whereas the minor enzyme (CB-II) is a single chain enzyme (Mr = 27,000). The NH2-terminal amino acid residues of CB-I were leucine and valine for the light and heavy chain, respectively. However, the NH2-terminal residue of CB-II was not available for automated Edman degradation. In addition, peptide mapping experiments indicated a difference in the primary structure of these two proteins. Despite such structural differences, they are similar in many enzymic properties. CB-I was more catalytically efficient than CB-II toward synthetic substrates, except for the substrate benzoyl-L-arginine beta-naphthylamide for which the relative catalytic efficiency is reversed. Both isozymes degraded glucagon by a dipeptidyl carboxypeptidase activity. Under the same conditions, CB-I was 4-5 times more efficient than CB-II. The results indicate that the cathepsin B isozymes are two separate gene products, but they are similar in enzymic properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722202

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

2.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Degradation of laminin by human tumor cathepsin B.

Authors:  T T Lah; M R Buck; K V Honn; J D Crissman; N C Rao; L A Liotta; B F Sloane
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

4.  Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver.

Authors:  D Brömme; K Bescherer; H Kirschke; S Fittkau
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

Review 5.  N-glycosylation/deglycosylation as a mechanism for the post-translational modification/remodification of proteins.

Authors:  T Suzuki; K Kitajima; S Inoue; Y Inoue
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

6.  Demonstration by electrospray mass spectrometry that the peptidyldipeptidase activity of cathepsin B is capable of rat cathepsin B C-terminal processing.

Authors:  A D Rowan; R Feng; Y Konishi; J S Mort
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  Human tumour cathepsin B. Comparison with normal liver cathepsin B.

Authors:  K Moin; N A Day; M Sameni; S Hasnain; T Hirama; B F Sloane
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

8.  On the tissue/species dependence of cathepsin B isozymes.

Authors:  S D Choudhury; M Lamsal; S K Agarwal; R Sharma; M Y Khan
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

9.  Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.

Authors:  Soo Chan Lee; Alicia Li; Silvia Calo; Makoto Inoue; Nam K Tonthat; Judith M Bain; Johanna Louw; Mari L Shinohara; Lars P Erwig; Maria A Schumacher; Dennis C Ko; Joseph Heitman
Journal:  Mol Microbiol       Date:  2015-06-17       Impact factor: 3.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.